April 2020 FDA Recall Drug by Masterpharm Llc
D-1269-2020 - Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

This Class I drug recall was voluntarily initiated by Masterpharm Llc on April 14, 2020 for the product Drug. The FDA reported the reason for recall as cross contamination with other products; finasteride plus 1.25mg capsules were found to contain minoxidil.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1269-2020

Reason for Recall
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Initiated
04-14-2020
Reported
05-20-2020
Quantity
7260 capsules

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Nationwide in the U.S.
Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Batch or Lot Expiration Information

Lot# 02-27-2020:04@11, Exp. August 25, 2020.